Cracking the Reimbursement Code for Cardiovascular AI
FDA clearance doesn’t guarantee payer coverage. Cardiovascular AI companies often find that Medicare and commercial payers evaluate new technologies using a very different set of questions before agreeing to reimburse them. This webinar brings together...
